drugset / Trial / NCT07325591
Efficacy and Safety of Tazbentetol in ALS Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objectives of this study are to examine the effects of tazbentetol on clinical measures of ALS, patient reported outcomes (PROs), long-term safety and tolerability.
Timeline
- Start
- 2026-03-01
- Primary completion
- 2027-12-31
- Completion
- 2028-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tazbentetol | Unknown | — | Oral |